XML 56 R42.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value of Assets and Liabilities Fair Value of Assets and Liabilities (Tables)
3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule Of Fair Value Assets and Liabilities Measured on Recurring Basis Table Text Block
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2025 and December 31, 2024 are summarized below (dollars in millions):
March 31, 2025: Fair Value Measurements Using:
 Total    Level 1        Level 2    Level 3    
Assets: (1)
Fixed maturity securities available-for-sale:
Corporate$55,720 $— $47,498 $8,222 
Canadian government4,996 — 4,996 — 
Japanese government6,105 — 6,105 — 
ABS5,520 — 3,625 1,895 
CMBS2,267 — 2,254 13 
RMBS1,502 — 1,502 — 
U.S. government1,963 1,886 73 
State and political subdivisions722 — 722 — 
Other foreign government5,712 — 5,682 30 
Total fixed maturity securities available-for-sale84,507 1,886 72,457 10,164 
Equity securities153 66 — 87 
Funds withheld at interest – embedded derivatives(216)— — (216)
Funds withheld at interest57 — — 57 
Cash equivalents3,873 3,862 11 — 
Short-term investments399 303 93 
Other invested assets:
Derivatives114 — 114 — 
Other17 — 17 — 
Total other invested assets131 — 131 — 
Other assets – derivatives— — 
Total$88,905 $6,117 $72,692 $10,096 
Liabilities:
Interest-sensitive contract liabilities – embedded derivatives$383 $— $— $383 
Other liabilities:
Funds withheld at interest – embedded derivatives(150)— — (150)
Derivatives488 — 487 
Total$721 $— $487 $234 
(1)Excludes limited partnerships that are measured at estimated fair value using the NAV per share (or its equivalent) as a practical expedient. As of March 31, 2025, the fair value of such investments was $963 million.
December 31, 2024:
 Fair Value Measurements Using:
 TotalLevel 1Level 2Level 3
Assets: (1)
Fixed maturity securities available-for-sale:
Corporate$50,991 $— $44,137 $6,854 
Canadian government5,016 — 5,016 — 
Japanese government4,445 — 4,445 — 
ABS5,040 — 3,254 1,786 
CMBS2,267 — 2,254 13 
RMBS1,317 — 1,317 — 
U.S. government2,464 2,379 80 
State and political subdivisions693 — 693 — 
Other foreign government5,384 — 5,354 30 
Total fixed maturity securities available-for-sale77,617 2,379 66,550 8,688 
Equity securities155 67 — 88 
Funds withheld at interest – embedded derivatives(215)— — (215)
Funds withheld at interest56 — — 56 
Cash equivalents2,055 2,053 — 
Short-term investments313 175 127 11 
Other invested assets:
Derivatives121 — 121 — 
Other17 — 17 — 
Total other invested assets 138 — 138 — 
Other assets – derivatives— — 
Total$80,121 $4,674 $66,817 $8,630 
Liabilities:
Interest-sensitive contract liabilities – embedded derivatives$435 $— $— $435 
Other liabilities:
Funds withheld at interest – embedded derivatives(160)— — (160)
Derivatives486 — 484 
Total$761 $— $484 $277 
(1)Excludes limited partnerships that are measured at estimated fair value using the NAV per share (or its equivalent) as a practical expedient. As of December 31, 2024, the fair value of such investments was $966 million.
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
The following table presents quantitative information about significant unobservable inputs used in Level 3 fair value measurements that are developed internally by the Company as of March 31, 2025 and December 31, 2024 (dollars in millions):
Estimated Fair Value      Valuation TechniqueUnobservable InputRange (Weighted Average) 
March 31, 2025December 31, 2024March 31, 2025December 31, 2024
Assets:
Corporate$352 $99 Market comparable securitiesLiquidity premium
2%
2%
EBITDA Multiple
6.2x-11.0x (9.3x)
6.7x-11.0x (9.7x)
ABS677 564 Market comparable securitiesLiquidity premium
0-20% (5%)
0-10% (3%)
U.S. government— Market comparable securitiesLiquidity premium
0-1% (1%)
— 
Equity securities31 33 Market comparable securitiesLiquidity premium
4%
4%
EBITDA Multiple
7.4x-11.8x (10.5x)
7.4x-12.8x (10.9x)
Funds withheld at interest – embedded derivatives24 22 Total return swapMortality
0-100%  (4%)
0-100%  (3%)
Lapse
0-35%  (18%)
0-35%  (18%)
Withdrawal
0-10%  (5%)
0-10%  (4%)
CVA
0-5%  (0%)
0-5%  (0%)
Crediting rate
1-4%  (2%)
1-4%  (2%)
Other assets – derivativesCredit default swapCredit spread
0-1% (0%)
0-1% (0%)
Probability of default
0-7% (0%)
0-8% (0%)
Liabilities:
Interest-sensitive contract liabilities – embedded derivatives – indexed products383 435 Discounted cash flowMortality
0-100%  (3%)
0-100% (3%)
Lapse
0-35%  (17%)
0-35% (17%)
Withdrawal
0-10%  (4%)
0-10% (4%)
Option budget projection
1-4%  (2%)
1-4% (2%)
Other liabilities – derivativesCredit default swapCredit spread
0-1% (0%)
0-1% (0%)
Probability of default
0-7% (0%)
0-8% (0%)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
For the three months ended March 31, 2025:
Fixed maturity securities available-for-sale
Funds 
withheld at interest –embedded derivatives, net (1)
Funds 
withheld at interest
Interest-sensitive contract 
liabilities – embedded derivatives
 CorporateForeign govtStructured securitiesU.S. and local govtEquity securitiesCash equivalentsShort-term investments
Fair value, beginning of period$6,854 $30 $1,799 $$88 $— $11 $(55)$56 $(435)
Total gains/losses (realized/unrealized)
Included in earnings, net:
Net investment income— — — — — — (1)— 
Investment related gains (losses), net(7)— — — — — (11)— — 
Interest credited— — — — — — — — 24 
Included in other comprehensive income (loss)39 — 20 — — — — — — 
Purchases (2)
1,514 — 196 — — — — — — 
Sales (2)
(44)— — — (1)— — — — — 
Settlements (2)
(140)— (114)(1)— — (6)— — 21 
Transfers into Level 3— 10 — — — — — — — 
Transfers out of Level 3— — (6)— — — (2)— — — 
Fair value, end of period$8,222 $30 $1,908 $$87 $— $$(66)$57 $(383)
Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Net investment income$$— $$— $— $— $— $— $(1)$— 
Investment related gains (losses), net(8)— — — — — (11)— — 
Interest credited— — — — — — — — — 
Included in other comprehensive income (loss)40 — 21 — — — — — — 
(1)Funds withheld at interest embedded derivative assets and liabilities are presented net for purposes of the rollforward.
(2)The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
For the three months ended March 31, 2024:
Fixed maturity securities available-for-sale
Funds 
withheld at interest –embedded derivatives, net (1)
Funds 
withheld at interest
Interest-sensitive contract 
liabilities – embedded derivatives
 CorporateForeign govtStructured securitiesU.S. and local govtEquity securitiesCash equivalentsShort-term investments
Fair value, beginning of period$4,933 $35 $1,425 $26 $70 $— $$(171)$54 $(415)
Total gains/losses (realized/unrealized)
Included in earnings, net:
Net investment income— — — — — — — 
Investment related gains (losses), net(24)— (2)— (3)— — 77 — — 
Interest credited— — — — — — — — — (20)
Included in other comprehensive income (loss)11 (2)— — — — — (1)— 
Purchases (2)
428 — 46 — — — 12 
Sales (2)
(119)— (23)— — — — — — — 
Settlements (2)
(118)— (60)(1)— — — — (1)25 
Transfers into Level 3— — 30 — — — — — — 
Transfers out of Level 3(34)— (21)— — — — — — — 
Fair value, end of period$5,079 $33 $1,398 $27 $69 $— $10 $(94)$55 $(398)
Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Net investment income$$— $$— $— $— $— $— $$— 
Investment related gains (losses), net(27)— (3)— (3)— — 77 — — 
Interest credited— — — — — — — — — 46 
Included in other comprehensive income (loss)12 (2)— — — — — (1)— 
(1)Funds withheld at interest embedded derivative assets and liabilities are presented net for purposes of the rollforward.
(2)The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
Financial Instruments Carrying Amounts And Estimated Fair Value [Table Text Block]
The following table presents the carrying values and estimated fair values of the Company’s financial instruments, which were not measured at fair value on a recurring basis, as of March 31, 2025 and December 31, 2024 (dollars in millions). For additional information regarding the methods and significant assumptions used by the Company to estimate these fair values, see Note 13 – “Fair Value of Assets and Liabilities” in the Notes to Consolidated Financial Statements included in the Company’s 2024 Annual Report. This table excludes any payables or receivables for collateral under repurchase/reverse repurchase agreements and other transactions. The estimated fair value of the excluded amount approximates carrying value as they equal the amount of cash collateral received/paid.
March 31, 2025:
Carrying 
Value (1)
Estimated 
Fair Value
Fair Value Measurement Using:
Level 1Level 2Level 3
Assets:
Mortgage loans$9,331 $8,864 $— $— $8,864 
Policy loans1,284 1,284 — 1,284 — 
Funds withheld at interest5,487 5,187 — — 5,187 
Limited partnerships – cost method65 86 — — 86 
Cash and cash equivalents1,278 1,278 1,278 — — 
Short-term investments55 55 55 — — 
Other invested assets1,123 912 71 838 
Accrued investment income1,059 1,059 — 1,059 — 
Liabilities:
Interest-sensitive contract liabilities (2)
$27,262 $27,140 $— $— $27,140 
Funds withheld at interest5,039 4,817 — — 4,817 
Long-term debt5,734 5,593 — — 5,593 
December 31, 2024:
Assets:
Mortgage loans$8,839 $8,422 $— $— $8,422 
Policy loans1,321 1,321 — 1,321 — 
Funds withheld at interest5,596 5,296 — — 5,296 
Limited partnerships – cost method64 88 — — 88 
Cash and cash equivalents1,271 1,271 1,271 — — 
Short-term investments50 50 50 — — 
Other invested assets1,064 862 71 788 
Accrued investment income986 986 — 986 — 
Liabilities:
Interest-sensitive contract liabilities (2)
$25,817 $25,540 $— $— $25,540 
Funds withheld at interest5,177 4,960 — — 4,960 
Long-term debt5,042 4,836 — — 4,836 
(1)Carrying values presented herein may differ from those in the Company’s condensed consolidated balance sheets because certain items within the respective financial statement captions may be measured at fair value on a recurring basis.
(2)Carrying values and estimated fair values presented herein include a reinsurance recoverable of $2.0 billion as of March 31, 2025 and December 31, 2024.